Differential effects of intrastriatal neurotensin(1-13) and neurotensin(8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat

European Journal of Neuroscience

Volumn 9, Issue 9, 1997, Pages 1838-1846

  Ferraro, Luca ^a   O'Connor, William Thomas ^b   Antonelli, Tiziana ^a   Fuxe, Kjell ^c   Tanganelli, Sergio ^d  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Neurotensin peptides; SR48692; Striatopallidal pathway

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; 4 AMINOBUTYRIC ACID; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUROTENSIN[8-13]; PERGOLIDE;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; GLOBUS PALLIDUS; MALE; MICRODIALYSIS; NEOSTRIATUM; NERVE ENDING; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ANIMALS; CORPUS STRIATUM; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; GLOBUS PALLIDUS; MALE; MICRODIALYSIS; NEUROTENSIN; PEPTIDE FRAGMENTS; PERFUSION; PERGOLIDE; PYRAZOLES; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROTENSIN;

EID: 0030928037     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.1997.tb00750.x     Document Type: Article

References (45)

1. 3H]N-propylnorapomorphine binding sites. Acta Physiol. Scand., 117, 299-301.
2. Alexander, G. E. and Crutcher, M. D. (1990) Functional architecture of basal ganglia circuits, neural substrates of parallel processing. Trends Neurosci., 13, 266-271.
3. Blaha, C. D., Coury, A., Fibiger, H. C. and Phillips, A. G. (1990) Effects of neurotensin on DA release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis. Neuroscience, 34, 699-705.
4. Carraway, R. and Leeman, S. E. (1973) The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalamus. J. Biol. Chem., 248, 6854-6861.
5. Da-Silva, S. L., Brandao, M. L. and Tomaz, C. (1989) Behavioral effects of neurotensin applied to periventricular structures of rats. Braz. J. Med. Biol. Res., 22, 711-715.
6. Drew, K. L., O'Connor, W. T., Kehr, J. and Ungerstedt, U. (1990) Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia. Eur. J. Pharmacol., 187, 385-397.
7. Ferré, S., O'Connor, W. T., Fuxe, K. and Ungerstedt, U. (1993) The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J. Neurosci., 13, 5402-5406.
8. 2 receptors as a major mechanism for the neuroleptic-like action of neurotensin. In Kitabgi, P. and Nemeroff, C. B. (eds), The Neurobiology of Neurotensin. Ann. N.Y. Acad. Sci., 668, 186-204.
9. Fuxe, K., O'Connor, W. T., Antonelli, T., Osborne, P. G., Tanganelli, S., Agnati, L. F. and Ungerstedt, U. (1992b) Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum. Proc. Natl Acad. Sci. USA, 89, 5591-5595.
10. Gerfen, C. R. (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci., 15, 133-139.
11. Granier, C., Van Rietschoten, J., Kitbagi, P., Poustis, C. and Freichet, P. (1982) Synthesis and characterization of neurotensin analogues for structure/activity relationship studies. Eur. J. Biochem., 124, 117-122.
12. Gully, D., Canton, M., Boidegrain, R., Jeanjean, F., Molimard, J. C., Poncelet, M., Gueudet, C., Heaulme, M., Leyris, R., Brouard, A., Pelaprat, D., Labbe-Jullie, C., Mazella, J., Soubrié, P., Maffrand, J. P., Rostene, W., Kitbagi, P. and Le Fur, G. (1993) Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc. Natl Acad. Sci. USA, 90, 65-69.
13. Hökfelt, T., Everitt B. J., Thedorsson-Norheim, E. and Goldstein, M. (1984) Occurrence of neurotensin-like immunoreactivity in subpopulation of hypothalamic, mesencephalic and medullary catecholamine neurons. J. Comp. Neurol., 22, 525-529.
14. Homykiewicz, O. (1973) Dopamine in the basal ganglia. Its role and therapeutic implications. Br. Med. Bull., 29, 172-178.
15. Kalivas, P. W. and Duffy, P. (1990) Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. J. Neurosci., 10, 2940-2949.
16. Kehr, J. and Ungerstedt, U. (1989) Fast estimation of GABA in microdialysis perfusates: effects of nipecotic acid and 3-mercaptopropionic acid. J. Neurochem., 55, 1309-1310.
17. Le, F., Cusack, B. and Richelson, E. (1996) The neurotensin receptor: is there more than one subtype? Trends Pharmacol., 17, 1-3.
18. Le Moine, C. and Bloch, B. (1995) D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol., 355, 418-426.
19. Levant, B. and Nemeroff, C. B. (1988) The psychobiology of neurotensin. In Ganten, D. and Pfaff, D. (eds), Current Topics in Neuroendochrinology, Vol. 8. Springer, Berlin, pp. 232-252.
20. 2 receptor agonist binding in rat neostriatal membranes. Neurosci. Lett., 55, 121-124.
21. 2 receptor in rat nucleus accumbens: a receptor binding and microdialysis study. J. Neural Transm. Gen. Sect., 102, 125-137.
22. Nemeroff, C. B. (1987) Interaction of neurotensin with dopamine neurons in the mammalian central nervous system: focus on limbic system sites. In Sandler, M., Feurestein, C. and Scatton, B. (eds), Neurotransmitter Interactions in the Basal Ganglia. Raven Press, New York, pp. 155-170.
23. Nemeroff, C. B. and Cain, S. T. (1985) Neurotensin-dopamine interactions in the CNS. Trends Pharmacol. Sci., 6, 201-205.
24. Nemeroff, C. B., Levant, B., Myers, B. and Bissette, G. (1992) Neurotensin, antipsychotic drugs, and schizophrenia: basic and clinical studies. In Kitabgi, P. and Nemeroff, C. B. (eds), The Neurobiology of Neurotensin. Ann. N.Y. Acad. Sci., 668, pp. 146-156.
25. O'Connor, W. T., Fuxe, K., Antonelli, T., Osborne, P. G., Tanganelli, S., Agnati, L. and Ungerstedt, U. (1991) Dopamine neurotensin interactions in the neostriatum: evidence for a substrate of neuronal plasticity. Posters Neurosci., 1, 13-17.
26. Osborne, P. G., O'Connor, W. T., Beck, O. and Ungerstedt, U. (1994) Acute vs chronic haloperidol: relationship between tolerance to catalepsy and caudate and accumbens DA, GABA and acetylcholine release. Brain Res., 643, 20-30.
27. Palacios, J. M. and Kuhar, M. J. (1981) Neurotensin receptors are located on dopamine-containing neurons in the rat midbrain. Nature, 294, 587-589.
28. Parent, A. and Hazrati, L. N. (1995) Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev., 20, 91-127.
29. Paxinos, G. and Watson, C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
30. Pinnock, R. D. and Woodruff, G. N. (1994) The non-peptide neurotensin receptor antagonist SR48692 is not a potent antagonist of NT(8-13) responses of rat substantia nigra neurones in vitro. Neurosci. Lett., 172, 175-178.
31. Quirion, R. (1983) Interactions between neurotensin and dopamine in the brain: an overview. Peptides, 4, 609-615.
32. Quirion, R., Rowe, W. B., Lapchak, P. A., Arauyo, D. M. and Beaudet, A. (1992) Distribution of neurotensin receptors in mammalian brains. What it is telling us about its interactions with other neurotransmitter systems. In Kitabgi, P. and Nemeroff, C. B. (eds), The Neurobiology of Neurotensin. Ann. N.Y. Acad. Sci., 668, 109-119.
33. 2 type receptors. Brain Res., 519, 255-260.
34. Ruggeri, M., Ungerstedt, U., Agnati, L. F., Mutt, V., Harfstrand, A. and Fuxe, F. (1987) Effects of CCK peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral microdialysis in the anaesthetized rat. Neurochem. Int., 10, 509-520.
35. Scheel-Kruger, J. (1986) Dopamine GABA interactions: evidence that GABA transmits, modulates and mediated dopaminergic function in the basal ganglia and the limbic system. Acta Neurol. Scand., 73, 9-54.
36. Schotte, A. and Leysen, J. E. (1989) Autoradiographic evidence for the localization of high affinity neurotensin binding sites on dopaminergic nerve terminals in the nigrostriatal and mesolimbic pathways in rat brain. J. Chem. Neuroanat., 2, 253-257.
37. Shandra, O. A., Hodlevskyi, L. S., Panenko, A. V., Vastianov, R. S. and Oliinyk, A. A. (1994) Effect of intracerebral administration of somatostatin and neurotensin on posture and movement disorders. Fiziol. Zh., 40, 71-77.
38. Shi, W. X. and Bunney, B. S. (1991) Neurotensin modulates autoreceptor mediated dopamine effects on midbrain dopamine cell activity. Brain Res., 543, 315-321.
39. Shi, W. X. and Bunney, B. S. (1992) Roles of intracellular cAMP and protein kinase A in the actions of dopamine and neurotensin on midbrain dopamine neurons. J. Neurosci., 12, 2433-2438.
40. Shibata, K., Yamada, K. and Furukawa, T. (1987) Possible neuronal mechanisms involved in neurotensin-induced catalepsy in mice. Psychopharmacol., 91, 288-292.
41. Sirinathsinghji, D. J. S. and Heavens, R. P. (1989) Stimulation of GABA release from the rat neostriatum and globus pallidus in vivo by corticotropin-releasing factor. Neurosci. Lett., 100, 203-209.
42. Steinberg, R., Brun, P., Fournier, M., Souilhac, J., Rodier, D., Mons, G., Terranova, J. P., Le Fur, G. and Soubrié, P. (1994) SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission. Neuroscience, 59, 921-929.
43. Tanganelli, S., von Euler, G., Fuxe, K., Agnati, L. F. and Ungerstedt, U. (1989) Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum. Brain Res., 502, 319-324.
44. 2 receptors in rat striatal membranes. Acta Physiol. Scand., 131, 625-626.
45. 2 receptors in rat striatal membranes following treatment with toluene. Acta Physiol. Scand., 135, 442-448.